Category:Hepatology

A

• AASLD guidelines classification scheme
• Acanthocyte
• Aceruloplasminemia
• Acute liver failure
• Acute liver failure case study one
• Acute liver failure causes
• Acute liver failure classification
• Acute liver failure cost-effectiveness of therapy
• Acute liver failure CT
• Acute liver failure differential diagnosis
• Acute liver failure echocardiography or ultrasound
• Acute liver failure epidemiology and demographics
• Acute liver failure future or investigational therapies
• Acute liver failure historical perspective
• Acute liver failure history and symptoms
• Acute liver failure laboratory findings
• Acute liver failure medical therapy
• Acute liver failure natural history, complications and prognosis
• Acute liver failure other diagnostic studies
• Acute liver failure other imaging findings
• Acute liver failure overview
• Acute liver failure pathophysiology
• Acute liver failure physical examination
• Acute liver failure primary prevention
• Acute liver failure risk factors
• Acute liver failure secondary prevention
• Acute liver failure surgery
• Alagille syndrome
• Alagille syndrome associated conditions
• Alagille syndrome laboratory tests
• Alagille syndrome overview
• Alanine transaminase
• Alcoholic liver disease
• Alcoholic liver disease (patient information)
• Alcoholic liver disease case study one
• Alcoholic liver disease causes
• Alcoholic liver disease cost-effectiveness of therapy
• Alcoholic liver disease CT
• Alcoholic liver disease differential diagnosis
• Alcoholic liver disease echocardiography or ultrasound
• Alcoholic liver disease epidemiology and demographics
• Alcoholic liver disease future or investigational therapies
• Alcoholic liver disease historical perspective
• Alcoholic liver disease history and symptoms
• Alcoholic liver disease laboratory findings
• Alcoholic liver disease medical therapy
• Alcoholic liver disease MRI
• Alcoholic liver disease natural history, complications and prognosis
• Alcoholic liver disease other diagnostic studies
• Alcoholic liver disease other imaging findings
• Alcoholic liver disease overview
• Alcoholic liver disease pathophysiology
• Alcoholic liver disease physical examination
• Alcoholic liver disease primary prevention
• Alcoholic liver disease risk factors
• Alcoholic liver disease screening
• Alcoholic liver disease secondary prevention
• Alcoholic liver disease Surgery
• Alcoholic liver disease x ray
• Alpha 1-antitrypsin deficiency
• Alpha 1-antitrypsin deficiency (patient information)
• Alpha 1-antitrypsin deficiency chest x ray
• Alpha 1-antitrypsin deficiency cost-effectiveness of therapy
• Alpha 1-antitrypsin deficiency CT
• Alpha 1-antitrypsin deficiency differential diagnosis
• Alpha 1-antitrypsin deficiency epidemiology and demographics
• Alpha 1-antitrypsin deficiency future or investigational therapies

A cont.

• Alpha 1-antitrypsin deficiency historical perspective
• Alpha 1-antitrypsin deficiency history and symptoms
• Alpha 1-antitrypsin deficiency laboratory tests
• Alpha 1-antitrypsin deficiency medical therapy
• Alpha 1-antitrypsin deficiency MRI
• Alpha 1-antitrypsin deficiency natural history
• Alpha 1-antitrypsin deficiency other diagnostic studies
• Alpha 1-antitrypsin deficiency other imaging findings
• Alpha 1-antitrypsin deficiency overview
• Alpha 1-antitrypsin deficiency pathophysiology
• Alpha 1-antitrypsin deficiency physical examination
• Alpha 1-antitrypsin deficiency primary prevention
• Alpha 1-antitrypsin deficiency risk factors
• Alpha 1-antitrypsin deficiency screening
• Alpha 1-antitrypsin deficiency secondary prevention
• Alpha 1-antitrypsin deficiency surgery
• Alpha 1-antitrypsin deficiency ultrasound
• Alpha-amanitin
• Amanullin
• Amanullinic acid
• Artificial extracorporeal liver support
• Ascending cholangitis (patient information)
• ATC code A05

B

• Banti's syndrome
• Beta-amanitin
• Bile
• Bile acid
• Bile acid sequestrant
• Bile canaliculus
• Bile duct
• Biliary atresia
• Biliary atresia (patient information)
• Biliary atresia case study one
• Biliary atresia causes
• Biliary atresia classification
• Biliary atresia cost-effectiveness of therapy
• Biliary atresia CT
• Biliary atresia differential diagnosis
• Biliary atresia echocardiography or ultrasound
• Biliary atresia epidemiology and demographics
• Biliary atresia future or investigational therapies
• Biliary atresia history and symptoms
• Biliary atresia laboratory findings
• Biliary atresia medical therapy
• Biliary atresia MRI
• Biliary atresia natural history, complications and prognosis
• Biliary atresia other diagnostic studies
• Biliary atresia other imaging findings
• Biliary atresia overview
• Biliary atresia pathophysiology
• Biliary atresia physical examination
• Biliary atresia prevention
• Biliary atresia surgery
• Biliary fistula
• Bilirubin
• Bilirubin (data page)
• Bioartificial liver device
• Budd-Chiari syndrome
• Budd-Chiari syndrome (patient information)
• Budd-Chiari syndrome case study one
• Budd-Chiari syndrome causes
• Budd-Chiari syndrome cost-effectiveness of therapy
• Budd-Chiari syndrome CT
• Budd-Chiari syndrome differential diagnosis
• Budd-Chiari syndrome echocardiography or ultrasound
• Budd-Chiari syndrome epidemiology and demographics
• Budd-Chiari syndrome future or investigational therapies

B cont.

• Budd-Chiari syndrome historical perspective
• Budd-Chiari syndrome history and symptoms
• Budd-Chiari syndrome laboratory findings
• Budd-Chiari syndrome medical therapy
• Budd-Chiari syndrome MRI
• Budd-Chiari syndrome natural history, complications and prognosis
• Budd-Chiari syndrome other diagnostic studies
• Budd-Chiari syndrome other imaging findings
• Budd-Chiari syndrome overview
• Budd-Chiari syndrome pathophysiology
• Budd-Chiari syndrome physical examination
• Budd-Chiari syndrome prevention
• Budd-Chiari syndrome risk factors
• Budd-Chiari syndrome surgery

C

• Canal of Hering
• Canals of Hering
• Carnitine palmitoyltransferase I deficiency
• Carnitine palmitoyltransferase II deficiency
• Ceruloplasmin
• Child-Pugh score
• Cholangiocarcinoma
• Cholangiocarcinoma (patient information)
• Cholangiocarcinoma case study one
• Cholangiocarcinoma causes
• Cholangiocarcinoma chest x ray
• Cholangiocarcinoma classification
• Cholangiocarcinoma cost-effectiveness of therapy
• Cholangiocarcinoma CT
• Cholangiocarcinoma differential diagnosis
• Cholangiocarcinoma echocardiography or ultrasound
• Cholangiocarcinoma electrocardiogram
• Cholangiocarcinoma epidemiology and demographics
• Cholangiocarcinoma future or investigational therapies
• Cholangiocarcinoma historical perspective
• Cholangiocarcinoma history and symptoms
• Cholangiocarcinoma laboratory findings
• Cholangiocarcinoma medical therapy
• Cholangiocarcinoma MRI
• Cholangiocarcinoma natural history
• Cholangiocarcinoma other diagnostic studies
• Cholangiocarcinoma other imaging findings
• Cholangiocarcinoma overview
• Cholangiocarcinoma pathophysiology
• Cholangiocarcinoma physical examination
• Cholangiocarcinoma primary prevention
• Cholangiocarcinoma risk factors
• Cholangiocarcinoma screening
• Cholangiocarcinoma secondary prevention
• Cholangiocarcinoma staging
• Cholangiocarcinoma surgery
• Cholecystitis
• Cholecystitis (patient information)
• Cholecystitis case study one
• Cholecystitis causes
• Cholecystitis classification
• Cholecystitis cost-effectiveness of therapy
• Cholecystitis CT
• Cholecystitis differential diagnosis
• Cholecystitis electrocardiogram
• Cholecystitis epidemiology and demographics
• Cholecystitis future or investigational therapies
• Cholecystitis historical perspective
• Cholecystitis history and symptoms
• Cholecystitis laboratory findings
• Cholecystitis medical therapy
• Cholecystitis MRI